SCHEMBL21891997

SCHEMBL21891997

Fc1ccc(-c2c[nH]nc2F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 2/20 0.41
NR4A2 P43354 1/20 0.40
MAPK14 Q16539 6/20 0.39
GCGR P47871 2/20 0.39
DAPK3 O43293 1/20 0.39
PRKD3 O94806 1/20 0.39
MAP4K4 O95819 1/20 0.39
PAK4 O96013 1/20 0.39
ABL1 P00519 1/20 0.39
NTRK1 P04629 1/20 0.39
LCK P06239 1/20 0.39
CSF1R P07333 1/20 0.39
RET P07949 1/20 0.39
IGF1R P08069 1/20 0.39
MET P08581 1/20 0.39
PDGFRB P09619 1/20 0.39
FGFR1 P11362 1/20 0.39
PRKACA P17612 1/20 0.39
FLT1 P17948 1/20 0.39
LTK P29376 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24213499 0.83 MEN1 (0.38) DYRK1AMAPK14GCGRRPS6KA3NOTUM
SCHEMBL17619924 0.81 MAPK14 (0.49) DYRK1ANR4A2MAPK14GCGRDAPK3
SCHEMBL8360337 0.79 DYRK1A (0.45) DYRK1ANR4A2MAPK14GCGRDAPK3
SCHEMBL22309816 0.76 DYRK1A (0.40) DYRK1ANR4A2MAPK14GCGRDAPK3
SCHEMBL11537253 0.76 DYRK1A (0.35) DYRK1ANR4A2MAPK14GCGRDAPK3
SCHEMBL22310257 0.75 NR4A2 (0.39) DYRK1ANR4A2MAPK14GCGRDAPK3
SCHEMBL22309068 0.75 NR4A2 (0.39) DYRK1ANR4A2MAPK14GCGRDAPK3
SCHEMBL1554633 0.74 MAPK14 (0.53) MAPK14GCGRPRKD3MAP4K4MAPK9
SCHEMBL1776218 0.74 CA12 (0.45) NR4A2MAPK14GCGRMAP4K4
SCHEMBL6077530 0.74 MAPK14 (0.53) MAPK14GCGRPRKD3MAP4K4MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12358878-B2 N-aromatic amide compounds, preparation methods and uses thereof SHENZHEN EDK PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2025-07-15 US disclosed
EP-3858811-B1 N-AROMATIC AMIDES COMPOUND AND PREPARATION METHOD AND USE THEREOF SHENZHEN EDK PHARMACEUTICAL TECH CO LTD (CN) 2024-07-17 EP disclosed
US-20230382870-A1 N-AROMATIC AMIDE COMPOUNDS, PREPARATION METHODS AND USES THEREOF SHENZHEN EDK PHARMACEUTICAL TECH CO LTD (CN) 2023-11-30 US disclosed
US-20230382870-A1 N-AROMATIC AMIDE COMPOUNDS, PREPARATION METHODS AND USES THEREOF SHENZHEN EDK PHARMACEUTICAL TECH CO LTD (CN) 2023-11-30 US disclosed
US-20230382870-A1 N-AROMATIC AMIDE COMPOUNDS, PREPARATION METHODS AND USES THEREOF SHENZHEN EDK PHARMACEUTICAL TECH CO LTD (CN) 2023-11-30 US disclosed
US-11760727-B2 N-aromatic amide compounds, preparation methods and uses thereof SHENZHEN EDK PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-09-19 US disclosed
US-11760727-B2 N-aromatic amide compounds, preparation methods and uses thereof SHENZHEN EDK PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-09-19 US disclosed
US-11760727-B2 N-aromatic amide compounds, preparation methods and uses thereof SHENZHEN EDK PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-09-19 US disclosed
US-20230115515-A1 PYRAZOLYLPROPANAMIDE COMPOUNDS AND USES THEREOF FOR TREATMENT OF PROSTATE CANCER UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2023-04-13 US disclosed
CN-110963957-B N-aromatic amide compound and preparation method and application thereof 深圳恩多凯医药科技有限公司 2021-10-22 CN disclosed
EP-3858811-A1 N-AROMATIC AMIDES COMPOUND AND PREPARATION METHOD AND USE THEREOF Shenzen EDK Pharmaceutical Technology Co., Ltd. (CN) 2021-08-04 EP disclosed
EP-3858811-A1 N-AROMATIC AMIDES COMPOUND AND PREPARATION METHOD AND USE THEREOF Shenzen EDK Pharmaceutical Technology Co., Ltd. (CN) 2021-08-04 EP disclosed
US-20210214311-A1 N-AROMATIC AMIDE COMPUNDS, PREPARATION METHODS AND USES THEREOF SHENZHEN EDK PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2021-07-15 US disclosed
US-20210214311-A1 N-AROMATIC AMIDE COMPUNDS, PREPARATION METHODS AND USES THEREOF SHENZHEN EDK PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2021-07-15 US disclosed
CN-110963957-A N-aromatic amide compound and preparation method and application thereof 深圳恩多凯医药科技有限公司 2020-04-07 CN disclosed
WO-2020063407-A1 N-AROMATIC AMIDES COMPOUND AND PREPARATION METHOD AND USE THEREOF 深圳恩多凯医药科技有限公司 2020-04-02 WO disclosed
WO-2020063407-A1 N-AROMATIC AMIDES COMPOUND AND PREPARATION METHOD AND USE THEREOF 深圳恩多凯医药科技有限公司 2020-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382870-A1 N-AROMATIC AMIDE COMPOUNDS, PREPARATION METHODS AND USES THEREOF H1-3, H1-0, NAT1 DYRK1A 3628/4885NR4A2 557/4885MAPK14 4016/4885
US-11760727-B2 N-aromatic amide compounds, preparation methods and uses thereof AR, BPHL, CYP19A1 DYRK1A 3817/4885NR4A2 640/4885MAPK14 3901/4885
US-20210214311-A1 N-AROMATIC AMIDE COMPUNDS, PREPARATION METHODS AND USES THEREOF AR, BPHL, CYP19A1 DYRK1A 3845/4885NR4A2 537/4885MAPK14 3889/4885
US-20230115515-A1 PYRAZOLYLPROPANAMIDE COMPOUNDS AND USES THEREOF FOR TREATMENT OF PROSTATE CANCER AR, KLK3, ACP3 DYRK1A 1957/4885NR4A2 1098/4885MAPK14 3312/4885
US-12358878-B2 N-aromatic amide compounds, preparation methods and uses thereof H1-3, H1-0, NAT1 DYRK1A 3628/4885NR4A2 557/4885MAPK14 4016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.